{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF03727",
      "entity_text" : "hexokinase",
      "entity_type" : "family"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1224" ],
      "Cellular_component" : [ "uniprot:SL-0039" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "The use of [18 F] fluorodeoxyglucose (FDG) in oncology is based on an increased glucose uptake in cancer cells by increased glucose transport through the cell membrane of malignant cells and an overexpression of the enzyme hexokinase.",
  "reading_complete" : "2020-08-03T14:17:01Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:09:44Z",
  "trigger" : "overexpression",
  "evidence" : [ "overexpression of the enzyme hexokinase" ],
  "pmc_id" : "3311230",
  "score" : 0
}